nodes	percent_of_prediction	percent_of_DWPC	metapath
Pamidronate—FDPS—prostate gland—urinary bladder cancer	0.0213	0.19	CbGeAlD
Pamidronate—FDPS—seminal vesicle—urinary bladder cancer	0.018	0.161	CbGeAlD
Pamidronate—FDPS—smooth muscle tissue—urinary bladder cancer	0.0151	0.135	CbGeAlD
Pamidronate—FDPS—renal system—urinary bladder cancer	0.0145	0.13	CbGeAlD
Pamidronate—FDPS—urethra—urinary bladder cancer	0.0142	0.127	CbGeAlD
Pamidronate—FDPS—female reproductive system—urinary bladder cancer	0.0116	0.104	CbGeAlD
Pamidronate—FDPS—vagina—urinary bladder cancer	0.0105	0.0938	CbGeAlD
Pamidronate—FDPS—lymph node—urinary bladder cancer	0.00679	0.0607	CbGeAlD
Pamidronate—Risedronate—PTGS2—urinary bladder cancer	0.00431	0.529	CrCbGaD
Pamidronate—Clodronate—PTGS2—urinary bladder cancer	0.00384	0.471	CrCbGaD
Pamidronate—Upper respiratory tract infection—Doxorubicin—urinary bladder cancer	0.000595	0.000676	CcSEcCtD
Pamidronate—Haemoglobin—Methotrexate—urinary bladder cancer	0.000594	0.000676	CcSEcCtD
Pamidronate—Haemorrhage—Methotrexate—urinary bladder cancer	0.000591	0.000672	CcSEcCtD
Pamidronate—Asthenia—Gemcitabine—urinary bladder cancer	0.000589	0.00067	CcSEcCtD
Pamidronate—Haematuria—Epirubicin—urinary bladder cancer	0.000588	0.000668	CcSEcCtD
Pamidronate—Urinary tract disorder—Methotrexate—urinary bladder cancer	0.000584	0.000664	CcSEcCtD
Pamidronate—Pruritus—Gemcitabine—urinary bladder cancer	0.000581	0.000661	CcSEcCtD
Pamidronate—Nausea—Thiotepa—urinary bladder cancer	0.00058	0.000659	CcSEcCtD
Pamidronate—Urethral disorder—Methotrexate—urinary bladder cancer	0.00058	0.000659	CcSEcCtD
Pamidronate—Sinusitis—Epirubicin—urinary bladder cancer	0.000578	0.000657	CcSEcCtD
Pamidronate—Feeling abnormal—Etoposide—urinary bladder cancer	0.000578	0.000657	CcSEcCtD
Pamidronate—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000575	0.000654	CcSEcCtD
Pamidronate—Pneumonia—Doxorubicin—urinary bladder cancer	0.000574	0.000652	CcSEcCtD
Pamidronate—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000574	0.000652	CcSEcCtD
Pamidronate—Pruritus—Fluorouracil—urinary bladder cancer	0.000571	0.000649	CcSEcCtD
Pamidronate—Infestation NOS—Doxorubicin—urinary bladder cancer	0.00057	0.000648	CcSEcCtD
Pamidronate—Infestation—Doxorubicin—urinary bladder cancer	0.00057	0.000648	CcSEcCtD
Pamidronate—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000564	0.000641	CcSEcCtD
Pamidronate—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000562	0.000639	CcSEcCtD
Pamidronate—Renal failure—Doxorubicin—urinary bladder cancer	0.000561	0.000637	CcSEcCtD
Pamidronate—Haemoglobin—Epirubicin—urinary bladder cancer	0.000556	0.000632	CcSEcCtD
Pamidronate—Stomatitis—Doxorubicin—urinary bladder cancer	0.000556	0.000632	CcSEcCtD
Pamidronate—Rhinitis—Epirubicin—urinary bladder cancer	0.000555	0.000631	CcSEcCtD
Pamidronate—Abdominal pain—Etoposide—urinary bladder cancer	0.000555	0.00063	CcSEcCtD
Pamidronate—Body temperature increased—Etoposide—urinary bladder cancer	0.000555	0.00063	CcSEcCtD
Pamidronate—Urinary tract infection—Doxorubicin—urinary bladder cancer	0.000554	0.00063	CcSEcCtD
Pamidronate—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.000554	0.00063	CcSEcCtD
Pamidronate—Haemorrhage—Epirubicin—urinary bladder cancer	0.000553	0.000629	CcSEcCtD
Pamidronate—Eye disorder—Methotrexate—urinary bladder cancer	0.000553	0.000628	CcSEcCtD
Pamidronate—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000553	0.000628	CcSEcCtD
Pamidronate—Asthenia—Cisplatin—urinary bladder cancer	0.000549	0.000624	CcSEcCtD
Pamidronate—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000549	0.000624	CcSEcCtD
Pamidronate—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.000547	0.000621	CcSEcCtD
Pamidronate—Haematuria—Doxorubicin—urinary bladder cancer	0.000544	0.000618	CcSEcCtD
Pamidronate—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000544	0.000618	CcSEcCtD
Pamidronate—Urethral disorder—Epirubicin—urinary bladder cancer	0.000543	0.000617	CcSEcCtD
Pamidronate—Angiopathy—Methotrexate—urinary bladder cancer	0.000537	0.00061	CcSEcCtD
Pamidronate—Sinusitis—Doxorubicin—urinary bladder cancer	0.000535	0.000608	CcSEcCtD
Pamidronate—Immune system disorder—Methotrexate—urinary bladder cancer	0.000534	0.000607	CcSEcCtD
Pamidronate—Dizziness—Fluorouracil—urinary bladder cancer	0.000534	0.000607	CcSEcCtD
Pamidronate—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000533	0.000606	CcSEcCtD
Pamidronate—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000532	0.000605	CcSEcCtD
Pamidronate—Chills—Methotrexate—urinary bladder cancer	0.000531	0.000603	CcSEcCtD
Pamidronate—Diarrhoea—Cisplatin—urinary bladder cancer	0.000524	0.000595	CcSEcCtD
Pamidronate—Alopecia—Methotrexate—urinary bladder cancer	0.000523	0.000594	CcSEcCtD
Pamidronate—Vomiting—Gemcitabine—urinary bladder cancer	0.000522	0.000594	CcSEcCtD
Pamidronate—Rash—Gemcitabine—urinary bladder cancer	0.000518	0.000589	CcSEcCtD
Pamidronate—Dermatitis—Gemcitabine—urinary bladder cancer	0.000517	0.000588	CcSEcCtD
Pamidronate—Eye disorder—Epirubicin—urinary bladder cancer	0.000517	0.000588	CcSEcCtD
Pamidronate—Hypersensitivity—Etoposide—urinary bladder cancer	0.000517	0.000587	CcSEcCtD
Pamidronate—Erythema—Methotrexate—urinary bladder cancer	0.000515	0.000585	CcSEcCtD
Pamidronate—Malnutrition—Methotrexate—urinary bladder cancer	0.000515	0.000585	CcSEcCtD
Pamidronate—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000515	0.000585	CcSEcCtD
Pamidronate—Headache—Gemcitabine—urinary bladder cancer	0.000515	0.000585	CcSEcCtD
Pamidronate—Flushing—Epirubicin—urinary bladder cancer	0.000514	0.000584	CcSEcCtD
Pamidronate—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000514	0.000584	CcSEcCtD
Pamidronate—Vomiting—Fluorouracil—urinary bladder cancer	0.000514	0.000584	CcSEcCtD
Pamidronate—Rhinitis—Doxorubicin—urinary bladder cancer	0.000513	0.000583	CcSEcCtD
Pamidronate—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000512	0.000582	CcSEcCtD
Pamidronate—Rash—Fluorouracil—urinary bladder cancer	0.000509	0.000579	CcSEcCtD
Pamidronate—Dermatitis—Fluorouracil—urinary bladder cancer	0.000509	0.000578	CcSEcCtD
Pamidronate—Headache—Fluorouracil—urinary bladder cancer	0.000506	0.000575	CcSEcCtD
Pamidronate—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000506	0.000575	CcSEcCtD
Pamidronate—Dysgeusia—Methotrexate—urinary bladder cancer	0.000504	0.000573	CcSEcCtD
Pamidronate—Asthenia—Etoposide—urinary bladder cancer	0.000503	0.000572	CcSEcCtD
Pamidronate—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000503	0.000572	CcSEcCtD
Pamidronate—Angiopathy—Epirubicin—urinary bladder cancer	0.000502	0.000571	CcSEcCtD
Pamidronate—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000502	0.000571	CcSEcCtD
Pamidronate—Immune system disorder—Epirubicin—urinary bladder cancer	0.0005	0.000568	CcSEcCtD
Pamidronate—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000499	0.000567	CcSEcCtD
Pamidronate—Back pain—Methotrexate—urinary bladder cancer	0.000498	0.000566	CcSEcCtD
Pamidronate—Chills—Epirubicin—urinary bladder cancer	0.000497	0.000564	CcSEcCtD
Pamidronate—Pruritus—Etoposide—urinary bladder cancer	0.000496	0.000564	CcSEcCtD
Pamidronate—Alopecia—Epirubicin—urinary bladder cancer	0.000489	0.000556	CcSEcCtD
Pamidronate—Nausea—Gemcitabine—urinary bladder cancer	0.000488	0.000555	CcSEcCtD
Pamidronate—Vomiting—Cisplatin—urinary bladder cancer	0.000487	0.000553	CcSEcCtD
Pamidronate—Rash—Cisplatin—urinary bladder cancer	0.000483	0.000549	CcSEcCtD
Pamidronate—Dermatitis—Cisplatin—urinary bladder cancer	0.000482	0.000548	CcSEcCtD
Pamidronate—Erythema—Epirubicin—urinary bladder cancer	0.000482	0.000548	CcSEcCtD
Pamidronate—Malnutrition—Epirubicin—urinary bladder cancer	0.000482	0.000548	CcSEcCtD
Pamidronate—Diarrhoea—Etoposide—urinary bladder cancer	0.00048	0.000545	CcSEcCtD
Pamidronate—Nausea—Fluorouracil—urinary bladder cancer	0.00048	0.000545	CcSEcCtD
Pamidronate—Eye disorder—Doxorubicin—urinary bladder cancer	0.000479	0.000544	CcSEcCtD
Pamidronate—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000478	0.000543	CcSEcCtD
Pamidronate—Anaemia—Methotrexate—urinary bladder cancer	0.000476	0.000541	CcSEcCtD
Pamidronate—Flushing—Doxorubicin—urinary bladder cancer	0.000475	0.00054	CcSEcCtD
Pamidronate—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000475	0.00054	CcSEcCtD
Pamidronate—Tension—Epirubicin—urinary bladder cancer	0.000473	0.000537	CcSEcCtD
Pamidronate—Dysgeusia—Epirubicin—urinary bladder cancer	0.000472	0.000536	CcSEcCtD
Pamidronate—Nervousness—Epirubicin—urinary bladder cancer	0.000468	0.000532	CcSEcCtD
Pamidronate—Back pain—Epirubicin—urinary bladder cancer	0.000466	0.00053	CcSEcCtD
Pamidronate—Angiopathy—Doxorubicin—urinary bladder cancer	0.000465	0.000528	CcSEcCtD
Pamidronate—Malaise—Methotrexate—urinary bladder cancer	0.000464	0.000528	CcSEcCtD
Pamidronate—Dizziness—Etoposide—urinary bladder cancer	0.000464	0.000527	CcSEcCtD
Pamidronate—Muscle spasms—Epirubicin—urinary bladder cancer	0.000463	0.000526	CcSEcCtD
Pamidronate—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000463	0.000526	CcSEcCtD
Pamidronate—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000462	0.000525	CcSEcCtD
Pamidronate—Leukopenia—Methotrexate—urinary bladder cancer	0.000461	0.000524	CcSEcCtD
Pamidronate—Chills—Doxorubicin—urinary bladder cancer	0.000459	0.000522	CcSEcCtD
Pamidronate—Nausea—Cisplatin—urinary bladder cancer	0.000455	0.000517	CcSEcCtD
Pamidronate—Alopecia—Doxorubicin—urinary bladder cancer	0.000453	0.000514	CcSEcCtD
Pamidronate—Cough—Methotrexate—urinary bladder cancer	0.000449	0.000511	CcSEcCtD
Pamidronate—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000447	0.000508	CcSEcCtD
Pamidronate—Convulsion—Methotrexate—urinary bladder cancer	0.000446	0.000507	CcSEcCtD
Pamidronate—Vomiting—Etoposide—urinary bladder cancer	0.000446	0.000507	CcSEcCtD
Pamidronate—Malnutrition—Doxorubicin—urinary bladder cancer	0.000446	0.000507	CcSEcCtD
Pamidronate—Erythema—Doxorubicin—urinary bladder cancer	0.000446	0.000507	CcSEcCtD
Pamidronate—Anaemia—Epirubicin—urinary bladder cancer	0.000445	0.000506	CcSEcCtD
Pamidronate—Agitation—Epirubicin—urinary bladder cancer	0.000443	0.000503	CcSEcCtD
Pamidronate—Rash—Etoposide—urinary bladder cancer	0.000442	0.000503	CcSEcCtD
Pamidronate—Dermatitis—Etoposide—urinary bladder cancer	0.000442	0.000502	CcSEcCtD
Pamidronate—Headache—Etoposide—urinary bladder cancer	0.000439	0.000499	CcSEcCtD
Pamidronate—Arthralgia—Methotrexate—urinary bladder cancer	0.000438	0.000498	CcSEcCtD
Pamidronate—Myalgia—Methotrexate—urinary bladder cancer	0.000438	0.000498	CcSEcCtD
Pamidronate—Tension—Doxorubicin—urinary bladder cancer	0.000437	0.000497	CcSEcCtD
Pamidronate—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000437	0.000496	CcSEcCtD
Pamidronate—Malaise—Epirubicin—urinary bladder cancer	0.000434	0.000494	CcSEcCtD
Pamidronate—Discomfort—Methotrexate—urinary bladder cancer	0.000433	0.000492	CcSEcCtD
Pamidronate—Nervousness—Doxorubicin—urinary bladder cancer	0.000433	0.000492	CcSEcCtD
Pamidronate—Syncope—Epirubicin—urinary bladder cancer	0.000432	0.000491	CcSEcCtD
Pamidronate—Leukopenia—Epirubicin—urinary bladder cancer	0.000431	0.00049	CcSEcCtD
Pamidronate—Back pain—Doxorubicin—urinary bladder cancer	0.000431	0.00049	CcSEcCtD
Pamidronate—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000429	0.000487	CcSEcCtD
Pamidronate—Confusional state—Methotrexate—urinary bladder cancer	0.000424	0.000481	CcSEcCtD
Pamidronate—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000423	0.000481	CcSEcCtD
Pamidronate—Cough—Epirubicin—urinary bladder cancer	0.00042	0.000478	CcSEcCtD
Pamidronate—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.00042	0.000478	CcSEcCtD
Pamidronate—Convulsion—Epirubicin—urinary bladder cancer	0.000417	0.000474	CcSEcCtD
Pamidronate—Infection—Methotrexate—urinary bladder cancer	0.000417	0.000474	CcSEcCtD
Pamidronate—Nausea—Etoposide—urinary bladder cancer	0.000417	0.000474	CcSEcCtD
Pamidronate—Hypertension—Epirubicin—urinary bladder cancer	0.000416	0.000473	CcSEcCtD
Pamidronate—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000414	0.00047	CcSEcCtD
Pamidronate—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000412	0.000468	CcSEcCtD
Pamidronate—Anaemia—Doxorubicin—urinary bladder cancer	0.000412	0.000468	CcSEcCtD
Pamidronate—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000411	0.000468	CcSEcCtD
Pamidronate—Arthralgia—Epirubicin—urinary bladder cancer	0.00041	0.000466	CcSEcCtD
Pamidronate—Myalgia—Epirubicin—urinary bladder cancer	0.00041	0.000466	CcSEcCtD
Pamidronate—Agitation—Doxorubicin—urinary bladder cancer	0.00041	0.000466	CcSEcCtD
Pamidronate—Anxiety—Epirubicin—urinary bladder cancer	0.000409	0.000465	CcSEcCtD
Pamidronate—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000406	0.000462	CcSEcCtD
Pamidronate—Discomfort—Epirubicin—urinary bladder cancer	0.000405	0.000461	CcSEcCtD
Pamidronate—Malaise—Doxorubicin—urinary bladder cancer	0.000402	0.000457	CcSEcCtD
Pamidronate—Anorexia—Methotrexate—urinary bladder cancer	0.0004	0.000455	CcSEcCtD
Pamidronate—Syncope—Doxorubicin—urinary bladder cancer	0.0004	0.000454	CcSEcCtD
Pamidronate—Leukopenia—Doxorubicin—urinary bladder cancer	0.000399	0.000454	CcSEcCtD
Pamidronate—Confusional state—Epirubicin—urinary bladder cancer	0.000396	0.000451	CcSEcCtD
Pamidronate—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000393	0.000447	CcSEcCtD
Pamidronate—Oedema—Epirubicin—urinary bladder cancer	0.000393	0.000447	CcSEcCtD
Pamidronate—Hypotension—Methotrexate—urinary bladder cancer	0.000393	0.000446	CcSEcCtD
Pamidronate—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000392	0.000445	CcSEcCtD
Pamidronate—Infection—Epirubicin—urinary bladder cancer	0.000391	0.000444	CcSEcCtD
Pamidronate—Cough—Doxorubicin—urinary bladder cancer	0.000389	0.000442	CcSEcCtD
Pamidronate—Shock—Epirubicin—urinary bladder cancer	0.000387	0.00044	CcSEcCtD
Pamidronate—Convulsion—Doxorubicin—urinary bladder cancer	0.000386	0.000439	CcSEcCtD
Pamidronate—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000386	0.000438	CcSEcCtD
Pamidronate—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000385	0.000438	CcSEcCtD
Pamidronate—Hypertension—Doxorubicin—urinary bladder cancer	0.000385	0.000437	CcSEcCtD
Pamidronate—Tachycardia—Epirubicin—urinary bladder cancer	0.000384	0.000436	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000383	0.000435	CcSEcCtD
Pamidronate—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.00038	0.000432	CcSEcCtD
Pamidronate—Insomnia—Methotrexate—urinary bladder cancer	0.00038	0.000432	CcSEcCtD
Pamidronate—Arthralgia—Doxorubicin—urinary bladder cancer	0.00038	0.000431	CcSEcCtD
Pamidronate—Myalgia—Doxorubicin—urinary bladder cancer	0.00038	0.000431	CcSEcCtD
Pamidronate—Anxiety—Doxorubicin—urinary bladder cancer	0.000378	0.00043	CcSEcCtD
Pamidronate—Paraesthesia—Methotrexate—urinary bladder cancer	0.000377	0.000429	CcSEcCtD
Pamidronate—Discomfort—Doxorubicin—urinary bladder cancer	0.000375	0.000426	CcSEcCtD
Pamidronate—Anorexia—Epirubicin—urinary bladder cancer	0.000375	0.000426	CcSEcCtD
Pamidronate—Dyspnoea—Methotrexate—urinary bladder cancer	0.000375	0.000426	CcSEcCtD
Pamidronate—Somnolence—Methotrexate—urinary bladder cancer	0.000374	0.000425	CcSEcCtD
Pamidronate—Dyspepsia—Methotrexate—urinary bladder cancer	0.00037	0.00042	CcSEcCtD
Pamidronate—Hypotension—Epirubicin—urinary bladder cancer	0.000367	0.000418	CcSEcCtD
Pamidronate—Confusional state—Doxorubicin—urinary bladder cancer	0.000367	0.000417	CcSEcCtD
Pamidronate—Decreased appetite—Methotrexate—urinary bladder cancer	0.000365	0.000415	CcSEcCtD
Pamidronate—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000364	0.000413	CcSEcCtD
Pamidronate—Oedema—Doxorubicin—urinary bladder cancer	0.000364	0.000413	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000363	0.000412	CcSEcCtD
Pamidronate—Fatigue—Methotrexate—urinary bladder cancer	0.000362	0.000412	CcSEcCtD
Pamidronate—Infection—Doxorubicin—urinary bladder cancer	0.000361	0.000411	CcSEcCtD
Pamidronate—Pain—Methotrexate—urinary bladder cancer	0.000359	0.000408	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000358	0.000407	CcSEcCtD
Pamidronate—Shock—Doxorubicin—urinary bladder cancer	0.000358	0.000407	CcSEcCtD
Pamidronate—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000357	0.000405	CcSEcCtD
Pamidronate—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000356	0.000405	CcSEcCtD
Pamidronate—Insomnia—Epirubicin—urinary bladder cancer	0.000356	0.000404	CcSEcCtD
Pamidronate—Tachycardia—Doxorubicin—urinary bladder cancer	0.000355	0.000404	CcSEcCtD
Pamidronate—Paraesthesia—Epirubicin—urinary bladder cancer	0.000353	0.000401	CcSEcCtD
Pamidronate—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000352	0.0004	CcSEcCtD
Pamidronate—Dyspnoea—Epirubicin—urinary bladder cancer	0.000351	0.000398	CcSEcCtD
Pamidronate—Somnolence—Epirubicin—urinary bladder cancer	0.00035	0.000397	CcSEcCtD
Pamidronate—Anorexia—Doxorubicin—urinary bladder cancer	0.000347	0.000394	CcSEcCtD
Pamidronate—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000346	0.000394	CcSEcCtD
Pamidronate—Dyspepsia—Epirubicin—urinary bladder cancer	0.000346	0.000393	CcSEcCtD
Pamidronate—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000344	0.00039	CcSEcCtD
Pamidronate—Decreased appetite—Epirubicin—urinary bladder cancer	0.000342	0.000388	CcSEcCtD
Pamidronate—Hypotension—Doxorubicin—urinary bladder cancer	0.00034	0.000386	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000339	0.000386	CcSEcCtD
Pamidronate—Fatigue—Epirubicin—urinary bladder cancer	0.000339	0.000385	CcSEcCtD
Pamidronate—Constipation—Epirubicin—urinary bladder cancer	0.000336	0.000382	CcSEcCtD
Pamidronate—Pain—Epirubicin—urinary bladder cancer	0.000336	0.000382	CcSEcCtD
Pamidronate—Body temperature increased—Methotrexate—urinary bladder cancer	0.000332	0.000377	CcSEcCtD
Pamidronate—Abdominal pain—Methotrexate—urinary bladder cancer	0.000332	0.000377	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000331	0.000377	CcSEcCtD
Pamidronate—Insomnia—Doxorubicin—urinary bladder cancer	0.000329	0.000374	CcSEcCtD
Pamidronate—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000327	0.000371	CcSEcCtD
Pamidronate—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000324	0.000369	CcSEcCtD
Pamidronate—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000324	0.000368	CcSEcCtD
Pamidronate—Somnolence—Doxorubicin—urinary bladder cancer	0.000323	0.000368	CcSEcCtD
Pamidronate—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000322	0.000365	CcSEcCtD
Pamidronate—Dyspepsia—Doxorubicin—urinary bladder cancer	0.00032	0.000364	CcSEcCtD
Pamidronate—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000316	0.000359	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000314	0.000357	CcSEcCtD
Pamidronate—Fatigue—Doxorubicin—urinary bladder cancer	0.000314	0.000356	CcSEcCtD
Pamidronate—Pain—Doxorubicin—urinary bladder cancer	0.000311	0.000354	CcSEcCtD
Pamidronate—Constipation—Doxorubicin—urinary bladder cancer	0.000311	0.000354	CcSEcCtD
Pamidronate—Body temperature increased—Epirubicin—urinary bladder cancer	0.000311	0.000353	CcSEcCtD
Pamidronate—Abdominal pain—Epirubicin—urinary bladder cancer	0.000311	0.000353	CcSEcCtD
Pamidronate—Hypersensitivity—Methotrexate—urinary bladder cancer	0.00031	0.000352	CcSEcCtD
Pamidronate—Asthenia—Methotrexate—urinary bladder cancer	0.000301	0.000343	CcSEcCtD
Pamidronate—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.0003	0.000341	CcSEcCtD
Pamidronate—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000297	0.000338	CcSEcCtD
Pamidronate—Pruritus—Methotrexate—urinary bladder cancer	0.000297	0.000338	CcSEcCtD
Pamidronate—Hypersensitivity—Epirubicin—urinary bladder cancer	0.00029	0.000329	CcSEcCtD
Pamidronate—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000288	0.000327	CcSEcCtD
Pamidronate—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000288	0.000327	CcSEcCtD
Pamidronate—Diarrhoea—Methotrexate—urinary bladder cancer	0.000287	0.000327	CcSEcCtD
Pamidronate—Asthenia—Epirubicin—urinary bladder cancer	0.000282	0.000321	CcSEcCtD
Pamidronate—Pruritus—Epirubicin—urinary bladder cancer	0.000278	0.000316	CcSEcCtD
Pamidronate—Dizziness—Methotrexate—urinary bladder cancer	0.000278	0.000316	CcSEcCtD
Pamidronate—Diarrhoea—Epirubicin—urinary bladder cancer	0.000269	0.000306	CcSEcCtD
Pamidronate—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000268	0.000305	CcSEcCtD
Pamidronate—Vomiting—Methotrexate—urinary bladder cancer	0.000267	0.000304	CcSEcCtD
Pamidronate—Rash—Methotrexate—urinary bladder cancer	0.000265	0.000301	CcSEcCtD
Pamidronate—Dermatitis—Methotrexate—urinary bladder cancer	0.000265	0.000301	CcSEcCtD
Pamidronate—Headache—Methotrexate—urinary bladder cancer	0.000263	0.000299	CcSEcCtD
Pamidronate—Asthenia—Doxorubicin—urinary bladder cancer	0.000261	0.000297	CcSEcCtD
Pamidronate—Dizziness—Epirubicin—urinary bladder cancer	0.00026	0.000296	CcSEcCtD
Pamidronate—Pruritus—Doxorubicin—urinary bladder cancer	0.000257	0.000293	CcSEcCtD
Pamidronate—Vomiting—Epirubicin—urinary bladder cancer	0.00025	0.000284	CcSEcCtD
Pamidronate—Nausea—Methotrexate—urinary bladder cancer	0.00025	0.000284	CcSEcCtD
Pamidronate—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000249	0.000283	CcSEcCtD
Pamidronate—Rash—Epirubicin—urinary bladder cancer	0.000248	0.000282	CcSEcCtD
Pamidronate—Dermatitis—Epirubicin—urinary bladder cancer	0.000248	0.000282	CcSEcCtD
Pamidronate—Headache—Epirubicin—urinary bladder cancer	0.000246	0.00028	CcSEcCtD
Pamidronate—Dizziness—Doxorubicin—urinary bladder cancer	0.000241	0.000273	CcSEcCtD
Pamidronate—Nausea—Epirubicin—urinary bladder cancer	0.000234	0.000265	CcSEcCtD
Pamidronate—Vomiting—Doxorubicin—urinary bladder cancer	0.000231	0.000263	CcSEcCtD
Pamidronate—Rash—Doxorubicin—urinary bladder cancer	0.000229	0.000261	CcSEcCtD
Pamidronate—Dermatitis—Doxorubicin—urinary bladder cancer	0.000229	0.00026	CcSEcCtD
Pamidronate—Headache—Doxorubicin—urinary bladder cancer	0.000228	0.000259	CcSEcCtD
Pamidronate—Nausea—Doxorubicin—urinary bladder cancer	0.000216	0.000246	CcSEcCtD
